CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quidel's ROA per quarter

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


Return On Assets (Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
Y / Y Total Assets Change 116.95 % 105.43 % 44.02 % 14.98 % 6.72 %
Y / Y Net Income Change 342.59 % 1435.07 % 1335.44 % 5226.93 % 61.96 %
Net Income (TTM) in Millions 948 810 371 155 88
Return On Assets (TTM) 61.26 % 64.05 % 36.17 % 16.64 % 9.84 %
Total Ranking # 52 # 46 # 78 # 207 # 485
Total Assets (TTM) in Millions 2,097 1,871 1,249 973 967
Seq. Total Assets Change 12.09 % 49.77 % 28.41 % 0.64 % 6.14 %
Seq. Net Income Change -62.12 % 102.41 % 243.33 % 68.13 % 31.38 %


Roa Comment
Quidel Corporation yielded Return on Asset in I. Quarter above company average, at 61.26 %.

Return on assets decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 16 other companies have achieved higher return on assets. While Return on assets total ranking has deteriorated compare to previous quarter from 46 to 52.

What is ROA?
Return On Assets Company Ranking
Within: No.
Industry # 6
Sector # 17
Overall # 52

Return On Assets Statistics
High Average Low
64.05 %
15.19 %
0.32 %
(Dec 31 2020)   (Sep. 30, 2015)


Financial Statements
Quidel's Assets $ 2,097 Millions QDEL's Balance sheet
Quidel's Income $ 178 Millions Quarterly QDEL's Income Statement
QDEL's Income by Division See QDEL's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
(Dec 31 2017)
FY 2017
(Dec 31 2016)
FY 2016
Y / Y Total Assets Change 105.43 % 12.96 % -13.78 % 140.89 % -4.49 %
Total Assets in Millions 1,871 911 806 935 388
Y / Y Net Income Change 1011.18 % -1.7 % - - -
Net Income in Millions 810 73 74 -8 -14
Return On Assets 43.3 % 8.01 % 9.2 % - -




Roa Comment
In the fiscal year 2020 ROA improved to 43.3 % compare to previous year, due to annual net income growth of 1011.18 % to $810.29 millions, while value of Quidel's overall assets grew just by 105.43 % to $1,871.16 millions, compare to $1,871.16 a year before.


More Return On Equity Ratios
Biotechnology & Drugs Industry Return On Asstes Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
QDEL's Roa Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Asstes
Lowest Ranking Return On Asstes
Roa for QDEL's Competitors
Roa for Quidel's Suppliers
Return On Asstes for QDEL's Customers

You may also want to know
QDEL's Roi QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons
QDEL's Annual Roi QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2021, within Healthcare Sector ROA
Agios Pharmaceuticals Inc   121.49 %
Manhattan Scientifics Inc  103.07 %
Ovid Therapeutics Inc   102.15 %
Alpha Pro Tech Ltd  88.57 %
Co diagnostics Inc   83.72 %
Fulgent Genetics Inc   81.65 %
Chemomab Therapeutics Ltd   80.22 %
Molecular Templates Inc   62.37 %
Quidel Corporation  61.26 %
Fortium Holdings Corp   56.25 %
Semler Scientific inc   51.99 %
Retractable Technologies Inc  50.14 %
Siga Technologies Inc  46.82 %
Sage Therapeutics Inc   43.89 %
Catalyst Pharmaceuticals Inc   41.52 %
Fitlife Brands Inc   40.00 %
Antares Pharma Inc   34.18 %
Bio rad Laboratories Inc   33.43 %
Innoviva inc   33.38 %
Integrity Applications Inc   32.75 %
Health Discovery Corp  32.25 %
Oramed Pharmaceuticals Inc   31.97 %
Idexx Laboratories Inc  31.27 %
Ironwood Pharmaceuticals inc   27.26 %
Bionexus Gene Lab Corp  26.82 %
National Research Corporation  26.50 %
Hologic Inc  25.71 %
Viemed Healthcare Inc   25.65 %
Lakeland Industries Inc  25.17 %
Regeneron Pharmaceuticals Inc   24.47 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MHO's Profile

Stock Price

MHO's Financials

Business Description

Fundamentals

Charts & Quotes

MHO's News

Suppliers

MHO's Competitors

Customers & Markets

Economic Indicators

MHO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071